Private Equity Portfolio Company
Neurotech
Lincoln, Rhode Island
United States
https://www.neurotechusa.com
Neurotech is dedicated to the development of sight-saving therapeutics for chronic retinal diseases. Neurotech's lead product (NT-501) is in clinical development for the treatment of retinal degeneration, including retinitis pigmentosa, an...
Private Equity Owner: NMT Capital (Nexus)
Acquisition Criteria
Investment Date:
Exit Date:
Status:
Add-on Acquisitions:
Industry (NAICS Code):
Testimonials
Become the next customer to share a success story about Private Equity Info's impact.
"Private Equity Info is critical to nearly every aspect of our role as an investment bank. We use it almost every day and the return on investment is clear."
Bob McCormack
"PEI is superior for our sales team. It cuts to the core. It’s the sweet spot in terms of what you’re paying and what you’re getting.”
